{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:12:50Z","timestamp":1776147170115,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"\n Background<\/jats:title>\n Methamphetamine (MA) addiction is a chronic relapsing disorder that impairs physical health, induces mental distress (e.g., anxiety), and triggers abnormal inflammatory and neurotransmitter responses, all contributing to high relapse rates. Mindfulness and yoga interventions may alleviate psychological distress and improve physical well-being in substance users; however, few studies have systematically investigated their comprehensive effects on physical function, inflammatory markers, neurotransmitter balance, and relapse intention in MA addicts, leaving a gap in non-pharmacological interventions for this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n This randomized controlled trial aimed to investigate the effects of a 24-week yoga intervention integrated with mindfulness components on multiple health outcomes among individuals with methamphetamine use disorder, ncluding physical function (assessed by Functional Movement Screening [FMS], reaction time, sleep quality, subjective fatigue, and creatine kinase [CK]), anxiety, inflammatory response (tumor necrosis factor-\n \u03b1<\/jats:italic>\n [TNF-\u03b1], interleukin-6 [IL-6], and interleukin-10 [IL-10]), heart rate variability (HRV), relapse-related neurotransmitters (dopamine [DA], serotonin [5-HT], and norepinephrine [NE]), and relapse intention.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Eighty MA addicts meeting DSM-5 criteria were randomly assigned to an experimental group (\n n<\/jats:italic>\n \u202f=\u202f41; 40-min mindfulness yoga sessions, three times weekly for 24\u202fweeks) or a control group (\n n<\/jats:italic>\n \u202f=\u202f39; no additional intervention). Assessments were conducted at baseline and post-intervention for all outcomes, with additional measurements at 4 and 12\u202fweeks for fatigue, CK, and inflammatory markers.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Following the 24-week intervention, the experimental group demonstrated significant improvements in sleep quality (PSQI score reduced from 14.32 to 8.41), anxiety levels (BAI score decreased), FMS total score (increased from 9.24 to 12.12), and reaction time (improved from 0.59\u202fs to 0.48\u202fs) compared to baseline and controls (\n p<\/jats:italic>\n \u202f&lt;\u202f0.01). Relapse intention (OCDS score reduced from 29.12 to 18.45) and NE levels significantly decreased, while DA and 5-HT levels significantly increased (\n p<\/jats:italic>\n \u202f&lt;\u202f0.01). The experimental group also showed enhanced parasympathetic activity (higher HF index, lower LF\/HF ratio; both\n p<\/jats:italic>\n \u202f&lt;\u202f0.01), reduced CK, TNF-\n \u03b1<\/jats:italic>\n , IL-6, and subjective fatigue, and elevated IL-10 levels (\n p<\/jats:italic>\n \u202f&lt;\u202f0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Compared with a traditional relaxation and stretching control condition, mindfulness yoga intervention demonstrated superior efficacy in improving physical function, sleep quality, and reaction ability of MA addicts. These findings support mindfulness yoga as a promising non-pharmacological intervention for MA addiction rehabilitation.<\/jats:p>\n <\/jats:sec>\n \n Clinical trial registration<\/jats:title>\n \n https:\/\/www.chictr.org.cn\/showproj.html?proj=40393<\/jats:uri>\n , Unique Identifier is ChiCTR1900024439.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1788887","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:37:00Z","timestamp":1776145020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of mindfulness yoga intervention on physical function, anxiety, inflammatory response, and relapse intention in methamphetamine addicts: a 24-week randomized controlled trial"],"prefix":"10.3389","volume":"14","author":[{"given":"Su Xia","family":"Chen","sequence":"first","affiliation":[{"name":"School of Educational Science, Xinjiang Normal University","place":["Xinjiang, Urumqi, China"]},{"name":"College of Marxism, Xinjiang Medical University","place":["\u00dcr\u00fcmqi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Xue","family":"Lyu","sequence":"additional","affiliation":[{"name":"Biology Teaching and Research Group, Chongqing Tongnan Experimental High School","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong Ji","family":"Hao","sequence":"additional","affiliation":[{"name":"School of Physical Education, Southwest University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[{"name":"Biology Teaching and Research Group, Chongqing Tongnan Experimental High School","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Jun","family":"Li","sequence":"additional","affiliation":[{"name":"School of Educational Science, Xinjiang Normal University","place":["Xinjiang, Urumqi, China"]},{"name":"Biology Teaching and Research Group, Chongqing Tongnan Experimental High School","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08897070802218554","article-title":"Pharmacotherapy of methamphetamine addiction: an update","volume":"29","author":"Ahmed","year":"2008","journal-title":"Subst Abus"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1196\/annals.1441.030","article-title":"Chronic stress, drug use, and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.116.238501","article-title":"Molecular, Behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment","volume":"362","author":"Moszczynska","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","article-title":"Pharmacological treatment of methamphetamine\/amphetamine dependence: a systematic review","volume":"34","author":"Siefried","year":"2020","journal-title":"CNS Drugs"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-244X-13-32","article-title":"Yoga for mental health: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Cramer","year":"2013","journal-title":"Front Psych"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/0893-164X.20.3.343","article-title":"Mindfulness meditation and substance use in an incarcerated population","volume":"20","author":"Bowen","year":"2006","journal-title":"Psychol Addict Behav"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the \"dark side\" of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/10826084.2011.640540","article-title":"Mindfulness and substance use intervention","volume":"47","author":"Black","year":"2012","journal-title":"Subst Use Misuse"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuroscience.2006.01.031","article-title":"Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone","volume":"139","author":"Pandey","year":"2006","journal-title":"Neuroscience"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"110109","DOI":"10.1016\/j.pnpbp.2020.110109","article-title":"Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4\/MyD88\/NF\u03baB signaling pathway in the mouse hippocampus","volume":"111","author":"Nazari","year":"2021","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpsychires.2015.07.013","article-title":"A systematic review of randomised control trials on the effects of yoga on stress measures and mood","volume":"68","author":"Pascoe","year":"2015","journal-title":"J Psychiatr Res"},{"key":"ref14","first-page":"785","article-title":"Comparative efficacy of mindfulness-based stress reduction and cognitive-behavioral therapy for chronic pain: a systematic review and meta-analysis","volume":"20","author":"Irwin","year":"2019","journal-title":"Pain Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsycho.2005.11.013","article-title":"The role of vagal function in the risk for cardiovascular disease and mortality","volume":"74","author":"Thayer","year":"2007","journal-title":"Biol Psychol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1111\/j.1749-6632.2010.05566.x","article-title":"Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling","volume":"1204","author":"McEwen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pscychresns.2010.08.006","article-title":"Mindfulness practice leads to increases in regional brain gray matter density","volume":"191","author":"Holzel","year":"2011","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.neuroimage.2008.12.061","article-title":"The underlying anatomical correlates of long-term meditation: larger hippocampal and orbitofrontal cortex volumes","volume":"45","author":"Luders","year":"2009","journal-title":"NeuroImage"},{"key":"ref19","first-page":"132","article-title":"Pre-participation screening: the use of fundamental movements as an assessment of function \u2013 part 2","volume":"1","author":"Cook","year":"2006","journal-title":"N Am J Sports Phys Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jbmt.2009.02.006","article-title":"Functional fitness improvements after a worksite-based yoga initiative","volume":"14","author":"Cowen","year":"2010","journal-title":"J Bodyw Mov Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1038\/s41598-021-97548-1","article-title":"Altered fecal microbiota composition in individuals who abuse methamphetamine","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1891\/jcop.2005.19.3.211","article-title":"Mindfulness-based relapse prevention for alcohol and substance use disorders","volume":"19","author":"Witkiewitz","year":"2005","journal-title":"J Cogn Psychother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"CD013753","DOI":"10.1002\/14651858.CD013753","article-title":"Mindfulness-based interventions for substance use disorders","volume":"7","author":"Goldberg","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/157015906775203273","article-title":"Emotion, decision-making and substance dependence: a somatic-marker model of addiction","volume":"4","author":"Verdejo-Garc\u00eda","year":"2006","journal-title":"Curr Neuropharmacol"},{"key":"ref26","first-page":"1015","article-title":"Prefrontal dopamine deficits in methamphetamine abusers correlate with impaired cognitive function","volume":"14","author":"Volkow","year":"2001","journal-title":"NeuroImage"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.explore.2010.12.003","article-title":"Mindfulness-based stress reduction vs. pharmacotherapy for primary chronic insomnia: a pilot randomized controlled clinical trial","volume":"7","author":"Manber","year":"2011","journal-title":"Explore (NY)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1037\/1072-5245.12.2.164","article-title":"Mindfulness-based stress reduction for health care professionals: results from a randomized trial","volume":"12","author":"Shapiro","year":"2005","journal-title":"Int J Stress Manag"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1788887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:37:01Z","timestamp":1776145021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1788887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2026.1788887"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1788887","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1788887"}}